Search

everythinglearnresearchcommunity

for

Search:↓

DPCP immunotherapy is effective for alopecia areata, and understanding influencing factors can improve treatment and satisfaction.

Low-dose intralesional corticosteroid treatment led to rapid hair regrowth in localized alopecia areata.

Allergies, especially both seasonal and food, increase the risk of developing alopecia areata.

Botulinum toxin type A injections are not effective for severe alopecia areata.

Some patients with severe alopecia areata developed skin darkening from their treatment, which may indicate a less effective response to the therapy.

Many treatments for alopecia areata have inconsistent results; for under 10s, use minoxidil with a corticosteroid, and for over 10s, add ILC and consider diphenylcyclopropenone for widespread cases.

The multi-injection plate is a less painful and more efficient method for treating patchy hair loss.

The combination therapy of microdermabrasion and steroid injections is more effective for treating scalp Alopecia Areata than steroid injections alone.

Cryotherapy and steroid injections are similarly effective and safe for treating alopecia areata.

Abatacept may help some people with alopecia areata regrow hair.

The method effectively delivers vaccines through the skin without needles.

Smaller, diluted corticosteroid injections reduce the risk of vision loss.

Abrocitinib effectively treats severe alopecia areata with significant improvement and no side effects.

IMTA can help regrow hair in severe alopecia areata when JAK inhibitors don't work well.

Pediatric alopecia areata is more immune-active than adult cases, suggesting age-specific treatments and potential use of JAK inhibitors.

Superficial cryotherapy significantly improves eyebrow hair growth in alopecia universalis patients.

Atopic dermatitis in kids with alopecia areata can predict poor response to topical immunotherapy.

Topical immunotherapy with SADBE and DPCP is most effective for short-term hair regrowth in children with severe alopecia areata.

Diffuse alopecia areata involves more inflammation and higher allergy-related antibodies than patchy types.

Topical immunotherapy for alopecia areata may work by creating immune cell clusters in the skin.

Contact immunotherapy can improve hair regrowth in alopecia areata patients.

Cryotherapy with precise temperature control is a promising treatment for alopecia areata.

Baricitinib combined with other immune therapies may safely and effectively treat severe scalp hair loss.

Most patients improved in both atopic dermatitis and alopecia areata with certain treatments, but some had worsened symptoms, suggesting personalized care is needed.

Dupilumab effectively treated severe alopecia areata in a child.

SADBE treatment led to complete hair regrowth in mice with alopecia areata by altering immune cell movement.

Transcutaneous vaccination using nanoparticles can enhance immune responses and reduce basal cell carcinomas.

Dupilumab may help treat alopecia areata in children with atopic dermatitis, but it can also cause new hair loss.

Contact sensitizers like DCP and SADBE are the most effective treatments for alopecia areata.

Pediatric dermatologists have varied preferences for treating alopecia areata in children, with no standard FDA-approved treatments and some using JAK inhibitors despite risks.